Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment

International Journal of Clinical Pharmacology and Therapeutics

Volumn 43, Issue 9, 2005, Pages 413-419

  Horackova, M ^a   Schuck O ^b   Komers, R ^b   Charvat, J ^a   Teplan, V ^b   Kvapil, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Albuminuria; Chronic renal impairment; Glomerular filtration rate; Renin angiotensin aldosterone system; Rofecoxib

Indexed keywords

ALBUMIN; ALDOSTERONE; CREATININE; CYSTATIN C; INULIN; PROSTAGLANDIN; RENIN; ROFECOXIB;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ANALGESIC NEPHROPATHY; ARTICLE; BACKACHE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG MECHANISM; FEMALE; FLUID INTAKE; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HEADACHE; HUMAN; INULIN CLEARANCE; KIDNEY TUBULE; KIDNEY TUBULE FUNCTION; LEG PAIN; MALE; PLASMA RENIN ACTIVITY; PROSTAGLANDIN URINE LEVEL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR DISEASE; SALT INTAKE; SHORT COURSE THERAPY; SODIUM METABOLISM; TUBULAR DYSFUNCTION; URINARY EXCRETION; WATER METABOLISM;

EID: 24944441826     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP43413     Document Type: Article

References (33)

1. Ahmad SR, Kortepeter C, Brinker A, Chen M, Beitz J 2002 Renal failure associated with the use of celecoxib and rofecoxib. Drug Saf 25: 537-544
2. Breyer MD, Breyer RM 2000 Prostaglandin E receptors and the kidney. Am J Physiol Ren Physiol 279: F12-F23
3. Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, Lasseter KC, Qwan H, Gertz BJ, FitzGerald GA 1999 Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 289: 735-741
4. Cheng HF, Wang JL, Harris RC 2000 Nitric oxide up-regulates cyclooxygenase-2 expression in cTALH. Am J Kidney Dis 279: F122-F128
5. Cheng HF, Wang JL, Zhang MZ, Wang SW, McKanna JA, Harris RC 2001 Genetic deletion of cyclooxygenase-2 prevents increased renin expression in response to ACE inhibition. Am J Physiol 280: F449-F450
6. Dilger K, Herrlinger C, Peters J, Seyberth HW, Schweer H, Klotz U 2002 Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects. J Clin Pharmacol 42: 985-994
7. Elseviers MM, de Schepper A, Corthouts R, Bosmans JL, Cosyn L, Lins RL, Matthys E, Roose R, Van Caesbroeck D, Walter I, Horackova M, Schwarz A, Svrcek P, Bonucchi D, Franek E, Morlans M, De Broe ME 1995 High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure. Kidney Int 48: 1316-1323
8. Hao CM, Koemhoff M, Guan Y, Redha R, Breyer MD 1999 Selective targeting of cyclooxygenase-2 reveals its role on renal medullary interstitial cell survival. Am J Physiol 277: F352-F359
9. Harding P, Sigmon DH, Alfie ME, Huang PL, Fishman MC, Beierwaltes WH, Carretero OA 1999 Cyclooxygenase-2 inhibition mediates increased renal renin content by low-sodium diet. Hypertension 29: 297-302
10. Ichihara A, Imig JD, Ischo EW, Navar LG 1998 Cyclooxygenase-2 participates on tubular flow-dependent afferent arteriolar tone: interaction with neuronal NOS. Am J Physiol 275: F605-F612
11. Ichihara A, Imig JD, Navar LG 1999 Cyclooxygenase-2 modulates afferent arteriolar response to increases on pressure. Hypertension 34: 843-847
12. Kammerl MC, Nüsing RM, Schweda F, Endelmann D, Stubanus M, Kees F, Lackner KJ, Fischereder M, Krämer BK 2001 Low sodium and furosemid-induced stimulation of the renin system in man is mediated by cyclooxygenase 2. Clin Pharmacol Ther 70: 474-486
13. Khan KN, Venturini CM, Bunch RT, Brassard JA, Koki AT, Morfia DL, Trump BF, Maziasz TJ, Alden CL 1998 Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal anti-inflammatory drug-related nephrotoxicity. Toxicol Pathol 26: 612-620
14. Kömhoff M, Gröne HJ, Klein T, Seyberth HW, Nüsing RM 1997 Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol 272: F460-F468
15. Levin A 2003 The advantage of a uniform terminology and staging system for chronic kidney disease (CKD). Nephrol Dial Transplant 18: 1446-1451
16. Möckel GW, Zhang L, Fogo AB, Hao CH, Pozzi A, Breyer MD 2003 COX2 activity promotes organic osmolyte accumulation and adaptation of renal medullary interstitial cells to hypertonic stress. J Biol Chem 278: 19352-19358
17. Morales E, Mucksavage JJ 2002 Cyclooxygenase-2 inhibitor-associated renal failure: case report with rofecoxib and review of the literature. Pharmacotherapy 22: 1317-1321
18. Nantel F, Meadows E, Denis D, Connolly B, Metters KM, Giaid A 1999 Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly. FEBS Lett 457: 475-477
19. Niccoli L, Bellino S, Cantini F 2002 Renal tolerability of three commonly employed non-steroidal anti-inflammatory drugs in elderly patients with osteoarthritis. Clin Exp Rheumatol 20: 201-207
20. Perazella MA, Eras J 2000 Are selective inhibitors nephrotoxic? Am J Kidney Dis 35: 937-940
21. Saito O, Guan Y, Qi Z, Davis LS, Kömhoff M, Sugimoto Y, Narumiya S, Breyer RM, Breyer MD 2003 Expression of the prostaglandin F receptor (FP) gene along mouse genitourinary tract. Am J Physiol Ren Physiol 284: F1164-F1170
22. Schlöndorff D 1993 Renal complication of nonsteroidal anti-inflammatory drugs. Kidney Int 44: 643-653
23. Schück O 1984 Examination of kidney function. Martinus Nijhoff Publishers, Boston
24. Schwartz JI, Vandormael K, Malice MP, Kalyani RN, Lasseter KC, Holmes GB, Gertz BJ, Gottesdiener KM, Laurenzi M, Redfern KJ, Brune K 2002 Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther 72: 50-61
25. Sural S, Sharma RK, Gupta A, Sharma AP, Gulati S 2000 Acute renal failure associated with liver disease in India: etiology and outcome. Ren Fail 22: 623-634
26. Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, Dilzer SC, Obrda O, Sondblad KJ, Gumbs CP, Ebel DL, Juan H, Larson PJ, Schwartz JI, Muslinger TA, Gertz BJ, Brater C, Yao SL 2000 Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving low-salt diet. A randomized, controlled trial. Ann Intern Med 133: 1-9
27. Vasbinder GB, Nelmans PJ, Kessels AG, Orion AA, de Leeuw PW, van Engelshoven JM 2001 Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 135: 401-411
28. Wang JL, Cheng HF, Harris RC 1999 Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension 34: 96-101
29. Whelton A, Schulman G, Wallemark C, Drower EJ, Isakson PC, Verburg KH, Geis GS 2000 Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 160: 1465-1470
30. Wolf G, Porth J, Stahl RAK 2000 Acute renal failure associated with rofecoxib. Ann Intern Med 133: 394
31. Woywodt A, Schwarz A, Mengel M, Haller H, Zeidler H, Kohler L 2001 Nephrotoxicity of selective COX-2 inhibitors. J Rheumatol 28: 2133-2135
32. Yang T, Singh I, Pham H, Sun D, Smart A, Schnermann JB, Briggs JP 1998 Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol 274: F481-F489
33. Yang T, Schnermann JB, Briggs JP 1999 Regulation of cyclooxygenase-2 expression in renal medulla by tonicity in vivo and in vitro. Am J Physiol 277: F1-F9